These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23026381)

  • 21. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil.
    Chungsomprasong P; Durongpisitkul K; Vijarnsorn C; Soongswang J; Lê TP
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1032-40. PubMed ID: 21648053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure of persistent ductus arteriosus in adults.
    Bentham JR; Thomson JD; Gibbs JL
    J Interv Cardiol; 2012 Oct; 25(5):501-4. PubMed ID: 22672406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-the-wire-technique device implantation.
    Butera G; Castaldi B; Macdonald ST
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):485-92. PubMed ID: 22511555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.
    Fu YC; Bass J; Amin Z; Radtke W; Cheatham JP; Hellenbrand WE; Balzer D; Cao QL; Hijazi ZM
    J Am Coll Cardiol; 2006 Jan; 47(2):319-25. PubMed ID: 16412854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
    Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
    Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences.
    Gallet R; Seemann A; Yamamoto M; Hayat D; Mouillet G; Monin JL; Gueret P; Couetil JP; Dubois-Randé JL; Teiger E; Lim P
    Am J Cardiol; 2013 Jun; 111(11):1619-24. PubMed ID: 23523059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure.
    Durongpisitkul K; Tang NL; Soongswang J; Laohaprasitiporn D; Nana A; Kangkagate C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S658-66. PubMed ID: 12403244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.
    Jones TK; Latson LA; Zahn E; Fleishman CE; Jacobson J; Vincent R; Kanter K;
    J Am Coll Cardiol; 2007 Jun; 49(22):2215-21. PubMed ID: 17543643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO.
    Learn CP; Holzer RJ; Daniels CJ; Torres AJ; Vincent JA; Moore JW; Armsby LB; Landzberg MJ; Bergersen L
    Catheter Cardiovasc Interv; 2013 May; 81(6):997-1005. PubMed ID: 23345073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
    Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience.
    Wang L; Cao S; Li J; Yang L; Liu Y; Ren J; Ma Q; Xing H; Li D; Tian D; Wan Y; Yu S; Chen T; Yang X; Yang J
    Ann Thorac Surg; 2012 Aug; 94(2):592-8. PubMed ID: 22626754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences].
    Kaya MG; Ozdoğru I; Baykan A; Doğan A; Inanç T; Doğdu O; Uzüm K; Narin N; Topsakal R; Ergin A; Oğuzhan A; Eryol NK
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):287-93. PubMed ID: 18984979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence and risk factors of atrial tachyarrhythmia before and after percutaneous closure of secundum atrial septal defect in patients over 40 years of age].
    Wang C; Zhao SH; Jiang SL; Huang LJ; Xu ZY; Ling J; Zheng H; Zhang GJ; Yan CW; Dai RP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):797-801. PubMed ID: 18070469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders.
    Paç FA; Balli S; Topaloğlu S; Ece I; Oflaz MB
    Anadolu Kardiyol Derg; 2012 May; 12(3):249-54. PubMed ID: 22381925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytopenia in congenital heart disease patients.
    Martínez-Quintana E; Rodríguez-González F
    Platelets; 2015; 26(5):432-6. PubMed ID: 24956383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous options for heart failure in adults with congenital heart disease.
    Mylotte D; Martucci G; Piazza N; McElhinney D
    Heart Fail Clin; 2014 Jan; 10(1):179-96. PubMed ID: 24275303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.